Mast Adds New Board Member
This article was originally published in Scrip
Mast Therapeutics has appointed Matthew Pauls to its board of directors. Currently Pauls is president, CEO and on the board of Strongbridge Biopharma PLC. and prior to this he was chief commercial officer of Insmed, Inc. Before this, he was senior vice-president, head of global commercial operations at Shire Pharmaceuticals. Previously, Pauls held senior positions at Bristol-Myers Squibb, in brand management and payor marketing, and at Johnson & Johnson in various US and global commercial roles.
Register for our free email digests: